KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 121 filers reported holding KALA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $72,000 | -81.6% | 59,719 | -60.1% | 0.00% | – |
| Q3 2021 | $392,000 | -81.5% | 149,513 | -62.6% | 0.00% | -100.0% |
| Q2 2021 | $2,117,000 | -32.7% | 399,464 | -14.4% | 0.00% | 0.0% |
| Q1 2021 | $3,145,000 | -2.6% | 466,712 | -2.0% | 0.00% | 0.0% |
| Q4 2020 | $3,228,000 | -9.8% | 476,019 | -0.2% | 0.00% | -50.0% |
| Q3 2020 | $3,579,000 | -28.6% | 477,085 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,014,000 | +19.2% | 477,085 | -0.4% | 0.00% | 0.0% |
| Q1 2020 | $4,207,000 | +138.1% | 478,891 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $1,767,000 | -4.0% | 478,891 | -0.9% | 0.00% | 0.0% |
| Q3 2019 | $1,840,000 | -35.3% | 483,374 | +8.4% | 0.00% | 0.0% |
| Q2 2019 | $2,844,000 | +20.2% | 446,003 | +55.8% | 0.00% | 0.0% |
| Q1 2019 | $2,367,000 | +89.2% | 286,184 | +11.9% | 0.00% | 0.0% |
| Q4 2018 | $1,251,000 | -19.3% | 255,760 | +62.7% | 0.00% | 0.0% |
| Q3 2018 | $1,551,000 | – | 157,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vahanian & Associates Financial Planning Inc. | 181,384 | $54,000 | 0.23% |
| Samsara BioCapital, LLC | 601,162 | $180,000 | 0.05% |
| Board of Trustees of The Leland Stanford Junior University | 688,701 | $207,000 | 0.01% |
| Matisse Capital | 36,800 | $11,000 | 0.01% |
| Knights of Columbus Asset Advisors LLC | 120,841 | $36,000 | 0.00% |
| Covestor Ltd | 11,972 | $4,000 | 0.00% |
| Ergoteles LLC | 219,461 | $66,000 | 0.00% |
| Virtu Financial LLC | 74,636 | $22,000 | 0.00% |
| IPG Investment Advisors LLC | 14,300 | $4,000 | 0.00% |
| Aquatic Capital Management LLC | 13,200 | $4,000 | 0.00% |